203,834 Shares in The Cooper Companies, Inc. $COO Acquired by Heartland Advisors Inc.

Key Points

• Heartland Advisors acquired 203,834 shares of Cooper Companies in the second quarter, worth approximately $14.6 million and representing about 0.10% of the company. Institutional investors and hedge funds collectively own 24.39% of COO.
• Cooper Companies exceeded quarterly expectations, reporting $1.21 in earnings per share versus the $1.10 consensus and $1.08 billion in revenue. Revenue increased 7.9% year over year, while fiscal 2026 EPS guidance is $4.58–$4.66.
• Analyst sentiment remains mixed, with ratings ranging from strong buy to sell; the consensus is Hold with an $81.64 price target. COO recently traded at $76.22, with a 52-week range of $58.89 to $89.83.

Heartland Advisors Inc. purchased a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 203,834 shares of the medical device company's stock, valued at approximately $14,617,000. Heartland Advisors Inc. owned about 0.10% of Cooper Companies at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of the business. Mitsubishi UFJ Asset Management Co. Ltd. grew its position in Cooper Companies by 6.0% during the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 421,948 shares of the medical device company's stock worth $34,224,000 after purchasing an additional 23,896 shares during the period. Swedbank AB lifted its holdings in shares of Cooper Companies by 18.8% in the 4th quarter. Swedbank AB now owns 1,074,029 shares of the medical device company's stock valued at $88,027,000 after buying an additional 170,000 shares during the period. Capital International Inc. CA boosted its stake in shares of Cooper Companies by 22.9% in the fourth quarter. Capital International Inc. CA now owns 118,210 shares of the medical device company's stock worth $9,688,000 after buying an additional 22,054 shares during the last quarter. SEB Asset Management AB purchased a new stake in shares of Cooper Companies in the first quarter worth about $22,823,000. Finally, Western Standard LLC acquired a new stake in Cooper Companies during the second quarter worth about $5,228,000. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Cooper Companies Price Performance

NASDAQ:COO opened at $76.22 on Friday. The company has a quick ratio of 0.78, a current ratio of 1.27 and a debt-to-equity ratio of 0.23. The Cooper Companies, Inc. has a 52 week low of $58.89 and a 52 week high of $89.83. The stock's 50-day moving average price is $71.93 and its 200-day moving average price is $71.16. The stock has a market capitalization of $14.87 billion, a PE ratio of 64.59, a price-to-earnings-growth ratio of 1.99 and a beta of 0.83.

Cooper Companies (NASDAQ:COO - Get Free Report) last released its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, topping analysts' consensus estimates of $1.10 by $0.11. The company had revenue of $1.08 billion during the quarter, compared to analysts' expectations of $1.05 billion. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.Cooper Companies's quarterly revenue was up 7.9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.96 EPS. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. As a group, equities analysts expect that The Cooper Companies, Inc. will post 4.63 EPS for the current fiscal year.

Analysts Set New Price Targets

Several research analysts recently weighed in on the company. Stifel Nicolaus reduced their price target on Cooper Companies from $95.00 to $85.00 and set a "buy" rating for the company in a research report on Friday, June 5th. Weiss Ratings lowered Cooper Companies from a "hold (c-)" rating to a "sell (d)" rating in a research report on Monday, June 8th. Wall Street Zen raised shares of Cooper Companies from a "hold" rating to a "buy" rating in a research note on Sunday, June 21st. Wells Fargo & Company reaffirmed a "sell" rating and set a $66.00 target price (down from $82.00) on shares of Cooper Companies in a report on Friday, June 5th. Finally, UBS Group assumed coverage on shares of Cooper Companies in a research note on Tuesday, July 28th. They issued a "neutral" rating and a $75.00 target price for the company. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat.com, Cooper Companies presently has a consensus rating of "Hold" and a consensus target price of $81.64.

About Cooper Companies

Cooper Companies, Inc NASDAQ: COO is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women's health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source